Fexofenadine/phenylephrine

Drug Profile

Fexofenadine/phenylephrine

Alternative Names: FEX60/PE10; Phenylephrine/fexofenadine

Latest Information Update: 09 Dec 2015

Price : $50

At a glance

  • Originator Sanofi
  • Class Acetic acids; Antiallergics; Benzhydryl compounds; Decongestants; Ethanolamines; Nonsedating antihistamines; Piperidines; Small molecules
  • Mechanism of Action Alpha 1 adrenergic receptor agonists; Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Allergic rhinitis

Most Recent Events

  • 01 Mar 2015 Phase-III clinical trials in Allergic rhinitis in Japan (PO) (NCT02401191)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top